These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18307140)

  • 1. Angiosarcoma of the eyelid and periorbital region. Experience in Leiden with iridium192 brachytherapy and low-dose doxorubicin chemotherapy.
    de Keizer RJ; de Wolff-Rouendaal D; Nooy MA
    Orbit; 2008; 27(1):5-12. PubMed ID: 18307140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement.
    DeMartelaere SL; Roberts D; Burgess MA; Morrison WH; Pisters PW; Sturgis EM; Ho V; Esmaeli B
    Head Neck; 2008 May; 30(5):639-46. PubMed ID: 18213722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiosarcoma of the eyelid: a clinicopathologic comparison between isolated unilateral tumors and tumors demonstrating extrapalpebral involvement.
    Papalas JA; Manavi CK; Woodward JA; Sangueza OP; Cummings TJ
    Am J Dermatopathol; 2010 Oct; 32(7):694-9. PubMed ID: 20559124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
    J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachytherapy with 192Ir as treatment of carcinoma of the tarsal structure of the eyelid.
    Conill C; Sánchez-Reyes A; Molla M; Vilalta A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1326-9. PubMed ID: 15275716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late chest wall toxicity after MammoSite breast brachytherapy.
    Brashears JH; Dragun AE; Jenrette JM
    Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interstitial brachytherapy of peri-orificial skin carcinomas on the face].
    Rio E; Bardet E; Ferron C; Peuvrel P; Supiot S; Campion L; Beauvillain De Montreuil C; Mahe MA; Dreno B
    Cancer Radiother; 2006 May; 10(3):101-6. PubMed ID: 16529964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy.
    Gómez-Iturriaga A; Pina L; Cambeiro M; Martínez-Regueira F; Aramendía JM; Fernández-Hidalgo O; Martínez-Monge R
    Brachytherapy; 2008; 7(4):310-5. PubMed ID: 18778971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy following recurrent angiosarcoma of the ovary--a case report and review of literature.
    Jha S; Chan KK; Poole CJ; Rollason TP
    Gynecol Oncol; 2005 Jun; 97(3):935-7. PubMed ID: 15943995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of angiosarcoma with liposomal-encapsulated doxorubicin].
    Voss A; Seitz CS; Rose C; Bröcker EB; Goebeler M
    Hautarzt; 2001 Oct; 52(10):895-8. PubMed ID: 17690822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous angiosarcoma is a rare aggressive malignant vascular tumour of the skin.
    Wollina U; Hansel G; Schönlebe J; Averbeck M; Paasch U; Uhl J; Hindemann W; Simon JC
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):964-8. PubMed ID: 21108661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the treatment of keloid scars still a challenge in 2006?
    De Lorenzi F; Tielemans HJ; van der Hulst RR; Rhemrev R; Nieman FH; Lutgens LC; Boeckx WD
    Ann Plast Surg; 2007 Feb; 58(2):186-92. PubMed ID: 17245147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.
    Martelli H; Haie-Meder C; Branchereau S; Franchi-Abella S; Ghigna MR; Dumas I; Bouvet N; Oberlin O
    J Pediatr Surg; 2009 Jan; 44(1):190-6. PubMed ID: 19159742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
    Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
    Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).
    de Crevoisier R; Slimane K; Sanfilippo N; Bossi A; Albano M; Dumas I; Wibault P; Fizazi K; Gerbaulet A; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1150-6. PubMed ID: 19395183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic.
    Nascimento AF; Raut CP; Fletcher CD
    Am J Surg Pathol; 2008 Dec; 32(12):1896-904. PubMed ID: 18813119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of radiation therapy after incomplete resection of penile cancer.
    Langsenlehner T; Mayer R; Quehenberger F; Prettenhofer U; Langsenlehner U; Pummer K; Kapp KS
    Strahlenther Onkol; 2008 Jul; 184(7):359-63. PubMed ID: 19016034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy.
    Ghadjar P; Keller T; Rentsch CA; Isaak B; Behrensmeier F; Stroux A; Thalmann GN; Aebersold DM
    Brachytherapy; 2009; 8(1):45-51. PubMed ID: 19038584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results.
    Patel RR; Christensen ME; Hodge CW; Adkison JB; Das RK
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):970-3. PubMed ID: 18313521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.